Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001586400 | SCV001812839 | likely benign | not provided | 2020-11-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001586400 | SCV003489387 | benign | not provided | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039480 | SCV004946343 | uncertain significance | Inborn genetic diseases | 2024-02-06 | criteria provided, single submitter | clinical testing | The c.2159C>T (p.A720V) alteration is located in exon 2 (coding exon 1) of the MYO15A gene. This alteration results from a C to T substitution at nucleotide position 2159, causing the alanine (A) at amino acid position 720 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |